ESAB Corporation Announces Third Quarter 2026 Results
• Updating 2026 outlook North Bethesda, MD, November 4, 2026 -- ESAB Corporation (“ESAB” or the “Company”) (NYSE: ESAB), a focused premier industrial compounder, today announced financial results for the third quarter of 2026.
ESAB reported record third quarter sales of $825 million, an increase of 13.3% on a reported basis or an increase of 2.3% on a core organic growth basis before acquisitions and currency translation, as compared to the prior year quarter. ESAB also reported third quarter net income from continuing operations attributable to ESAB of $41 million or $0.61 diluted earnings per share and core adjusted net income of $83 million or $1.30 diluted earnings per share. Core adjusted EBITDA of $156 million rose 17.0% and core adjusted EBITDA margin expanded by 40 basis points on a year-over-year basis to 19.8%.
“ESAB delivered record third quarter core sales and adjusted EBITDA, with organic growth in both segments, despite a dynamic global environment and continued inflationary pressure. We improved sales, margins and cash generation sequentially. Disciplined execution, investment in growth and our EBXai operating system are delivering results,” said Shyam P. Kambeyanda, ESAB President and CEO. “We built this enterprise to win in any market, and we are executing with urgency to capture the opportunities ahead.”
“ESAB is setting the standard for complete workflow solutions,” Kambeyanda added. “With our new products, and the acquisitions of EWM and Eddyfi, we now serve our customers across the entire life of their most critical assets, from the first cut and weld through decades of inspection, monitoring and repair. At Fabtech, customers saw the full strength and power of our enterprise firsthand, and their response was overwhelmingly positive. We are beginning to convert this into new growth, from cross-selling opportunities at ESAB and Eddyfi. Lastly, we remain relentlessly focused on execution and on turning our unrivaled position into lasting value for our shareholders.”
ESAB has updated its full-year 2026 outlook, which now projects total core sales growth of 13.1% to 13.3%, compared with the previous guidance of 11.0% to 14.0%. Within this growth, core organic sales growth is now expected to be 1.6% to 2.0%, down from the prior range of 2.0% to 4.0%. The contribution from M&A has increased to appro ximately 9.5% from the prior guidance of 9.0%, and the anticipated FX impact has increased to approximately 2.0% from the prior range of 0.0% to 1.0%. As a result, the company has adjusted its core adjusted EBITDA forecast to a range of $603 million to $607 million, down from the previous $615 million to $625 million. The outlook for core adjusted EPS has been adjusted to a range of $5.28 to $5.33, from the prior $5.40 to $5.50.
Founded in 1904, ESAB Corporation is a focused industrial compounder. The Company’s rich history of innovative products, workflow solutions and its business system ESAB Business Excellence with AI (“EBXai”), enables the Company’s purpose of Shaping the world we imagine TM . ESAB Corporation is based in North Bethesda, Maryland and employs approximately 11,300 associates and serves customers in approximately 150 countries. To learn more, visit www.ESABcorporation.com.
The Company will hold a conference call to discuss its third quarter 2026 results beginning at 8:00 a.m. Eastern on Wednesday, November 4, 2026, which will be open to the public by calling +1-585-542-9983 (U.S. callers) and +1-833-461-5787 (International callers) and referencing the conference ID number 463934714 and through webcast via ESAB’s website www.ESABcorporation.com under the “Investors” section. Access to a supplemental slide presentation can also be found on ESAB's website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call. The Company’s quarterly report on Form 10-Q for the fiscal quarter ended October 2, 2026, filed November 4, 2026, is also available on ESAB’s website under the “Investors” section. 1
ESAB has provided in this press release financial information that has not been prepared in accordance with accounting principles generally accepted in the United States (“non-GAAP”). ESAB presents some of these non-GAAP financial measures including and excluding Russia d ue to economic and political volatility caused by the war in Ukraine, which results in enhanced investor interest in this information. Core non-GAAP financial measures exclude Russia for the three and nine months ended October 2, 2026 and October 3, 2025 . T hese non-GAAP financial measures may include one or more of the following: adjusted net income from continuing operations, Core adjusted net income from continuing operations, adjusted gross profit, adjusted EBITDA (earnings before interest, taxes, Restructuring and other related charges, Pension settlement loss, acquisition transaction, due diligence and integration expenses, amortization of intangibles and fair value step up on acquired inventories, depreciation and other amortization and other costs such as compensation expense related to the Performance Option Awards), Core adjusted EBITDA, organic sales, Core organic sales, adjusted free cash flow and ratios based on the foregoing measures. ESAB also provides adjusted EBITDA and adjusted EBITDA margin on a segment basis, as well as Core adjusted EBITDA and Core adjusted EBITDA margin on a segment basis.
Adjusted gross profit represents Gross profit excluding inventory fair value step-up, which is the fair value adjustment to acquired inventory recognized in cost of sales as that inventory is sold. Adjusted gross profit margin is adjusted gross profit as a percentage of net sales. ESAB presents adjusted gross profit to show gross profit excluding the purchase accounting effect of acquired inventory, which management uses to supplement GAAP results and evaluate underlying gross margin trends across periods affected by acquisitions. ESAB is presenting adjusted gross profit for the first time, and prior-period amounts are calculated on the same basis. ESAB will present adjusted gross profit on this basis for all periods presented going forward. If ESAB changes this definition, it will revise prior periods presented for consistency and disclose the change and its effect on margin.
Adjusted net income from continuing operations represents Net income from continuing operations attributable to ESAB Corporation, excluding Restructuring and other related charges, Pension settlement loss, acquisition transaction, due diligence and integration expenses, amortization of intangibles and fair value step up on acquired inventories and other costs such as compensation expense related to the Performance Option Awards. Adjusted net income, includes the tax effect of non-GAAP adjusting items at applicable tax rates and excludes the impact of discrete tax charges or gains in each period. ESAB also presents adjusted net income margin from continuing operations, which is subject to the same adjustments as adjusted net income from continuing operations. Adjusted net income per diluted share from continuing operations is a calculation of adjusted net income from continuing operations over the weighted-average diluted shares outstanding. ESAB also presents Core adjusted net income from continuing operations and Core adjusted net income per share - diluted from continuing operations, which are subject to the same adjustments as Adjusted net income from continuing operations and Adjusted net income per diluted share from continuing operations, further removing the impact of Russia for the three and nine months ended October 2, 2026 and October 3, 2025. We present the earnings per share-related non-GAAP measures on a basis that assumes the MCPS had already been converted as of the beginning of the applicable period (and accordingly also exclude the dividends accrued on the MCPS during such period, since such dividends would no longer be paid once the MCPS convert). We believe this presentation provides useful information to investors by helping them understand what the net impact will be on ESAB’s earnings per share - related measures once the MCPS convert into ESAB’s Common stock.
Adjusted EBITDA excludes from Net income from continuing operations the effect of Income tax expense, Interest expense and other, net, Restructuring and other related charges, Pension settlement loss, acquisition transaction, due diligence and integration expenses, amortization of intangibles and fair value step up on acquired inventories, depreciation and other amortization and other costs such as compensation expense related to the Performance Option Awards. ESAB presents adjusted EBITDA margin, which is subject to the same adjustments as adjusted EBITDA. Further, ESAB presents these non-GAAP performance measures on a segment basis, which excludes the impact of Restructuring and other related charges, acquisition transaction, due diligence and integration expenses, amortization of intangibles and fair value step up on acquired inventories, depreciation and other amortization and other costs such as compensation expense related to the Performance Option Awards from operating income. ESAB also presents Core adjusted EBITDA and Core adjusted EBITDA margin, which are subject to the same adjustments as Ad justed EBITDA and Adjusted EBITDA margin, respectively, further removing the impact of Russia for the three and nine months ended October 2, 2026 and October 3, 2025 .
ESAB presents organic sales, which excludes the impact of acquisitions and foreign exchange rate fluctuations and presents core organic sales, which further excludes the impact of the Russia business for the three and nine months ended October 2, 2026 and October 3, 2025 . 2 Adjusted free cash flow represents cash flows from operating activities excluding cash outflows related to discontinued operations and acquisition- related payments less purchases of property, plant and equipment.
These non-GAAP financial measures assist ESAB management in comparing its operating performance over time because certain items may obscure underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to unusual events or discrete restructuring plans and other initiatives that are fundamentally different from the ongoing productivity and core business of the Company.
ESAB management also believes that presenting these measures allows investors to view its performance using the same measures that the Company uses in evaluating its financial and business performance and trends.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.
This press release includes forward-looking statements, including forward- looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning the Company’s plans, goals, objectives, outlook, expectations, and intentions, and other statements that are not historical or current fact. Forward-looking statements are based on the Company’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements, including general risks and uncertainties such as market conditions, economic conditions, geopolitical events, changes in laws, regulations or accounting rules, fluctuations in interest rates, terrorism, wars or conflicts, major health concerns, natural disasters or other disruptions of expected business conditions. Factors that could cause the Company’s results to differ materially from current expectations include, but are not limited to, risks related to the impact of the war in Ukraine and the conflict in the Middle East and the resulting escalating geopolitical tensions; impact of supply chain disruptions; the impact of creditworthiness and financial viability of customers; impact of inflationary pressures, tariffs and trade policies, foreign exchange fluctuations and commodity prices; other impacts on the Company’s business and ability to execute business continuity plans; and the other factors detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission (“SEC”) on February 20, 2026, and the Form 10-Q for the quarterly period ended April 3, 2026 filed with the SEC on May 7, 2026 and the Form 10-Q for the quarterly period ended July 3, 2026 filed with the SEC on August 6, 2026, as well as other risks discussed in the Company’s filings with the SEC. In addition, these statements are based on assumptions that are subject to change. This press release speaks only as of the date hereof. The Company disclaims any duty to update the information herein.
(2) Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets, costs associated with disposing of discontinued products and other costs in connection with the closure and optimization of facilities and product lines.
(3) Includes transaction, diligence and integration expenses totaling $8.8 million and $43.9 million for the three and nine months ended October 2, 2026, respectively, and $6.1 million and $20.4 million for the three and nine months ended October 3, 2025, respectively. Additionally, it includes amortization of intangibles and fair value step up on acquired inventories totaling $31.2 million and $60.1 million for the three and nine months ended October 2, 2026, respectively, and $10.3 million and $27.3 million for the three and nine months ended October 3, 2025, respectively. Additionally, includes $4.8 million of bridge loan commitment fees related to the Eddyfi Technologies acquisition for the nine months ended October 2, 2026.
(4) Includes the impact of the Performance Option Awards granted in June and July 2026. These awards were non-cash, one-time, non-recurring grants with a different structure and size than the Company’s annual equity compensation program totaling $2.8 million and $3.5 million for the three and nine months ended October 2, 2026, respectively.
(5) This line item reflects the aggregate tax effect of all non-tax adjustments reflected in the preceding line items of the table. ESAB estimates the tax effect of each adjustment by applying ESAB’s overall estimated effective tax rate to the pretax amount, unless the nature of the 5 item and/or tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment. The MCPS dividends are not tax deductible and therefore the tax effect of the adjustments reflected in the table above does not include any tax impact of the MCPS dividends.
(6) For 2026, discrete adjustments relate to tax effects from the Eddyfi transaction.
(7) In June 2026, the Company issued $175.0 million in aggregate liquidation preference of the MCPS. Dividends on the MCPS are payable on a cumulative basis at an annual rate of 6.50% on the liquidation preference of $1,000 per share. Unless earlier converted, each share of MCPS will automatically convert on approximately June 2029 into between 7.1806 and 8.2576 shares of ESAB's Common stock, subject to further anti-dilution adjustments. The number of shares of ESAB's Common stock issuable on conversion of the MCPS will be determined based on the volume weighted average price ("VWAP") per share of the Company's Common stock over the 20 consecutive trading day period commencing on, and including, the 21st scheduled trading day immediately preceding the final dividend payment date. For the purposes of calculating adjusted net income per share, the Company has excluded the paid and anticipated MCPS cash dividends and assumed the 'if- converted' method of share dilution (the incremental shares of Common stock deemed outstanding applying the 'if-converted' method of calculating share dilution are referred to as the 'Converted Shares'). Under this method, approximately 1.4 million and 0.7 million Converted Shares were included in weighted average diluted shares outstanding for the three and nine months ended October 2, 2026, respectively. We believe this presentation provides useful information to investors by helping them understand what the net impact will be on ESAB’s earnings per share - related measures once the MCPS convert into ESAB’s Common stock.
(8) Numbers calculated following the same definition as Adjusted net income from continuing operations for total Company. 6
(2) Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets, costs associated with disposing of discontinued products and other costs in connection with the closure and optimization of facilities and product lines.
(3) Includes transaction, diligence and integration expenses totaling $8.8 million and $43.9 million for the three and nine months ended October 2, 2026, respectively, and amortization of intangibles and fair value step up on acquired inventories totaling $31.2 million and $60.1 million for the three and nine months ended October 2, 2026, respectively.
(4) Includes the impact of the Performance Option Awards granted in June and July 2026. These awards were non-cash, one-time, non-recurring grants with a different structure and size than the Company’s annual equity compensation program totaling $2.8 million and $3.5 million for the three and nine months ended October 2, 2026, respectively.
(5) Numbers calculated following the same definition as Adjusted EBITDA for total Company.
(6) Net sales w ere $37.7 million and $110.2 million r elating to Russia for the three and nine months ended October 2, 2026, respectively. 7
(2) Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.
(3) Includes transaction, diligence and integration expenses totaling $6.1 million and $20.4 million for the three and nine months ended October 3, 2025, respectively, and amortization of intangibles and fair value step up on acquired inventories totaling $10.3 million and $27.3 million for the three and nine months ended October 3, 2025, respectively.
(4) Numbers calculated following the same definition as Adjusted EBITDA for total Company.
(5) Net sales were $40.4 million and $108.8 million relating to Russia for the three and nine months ended October 3, 2025, respectively. 8
(2) Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.
(3) Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(4) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.
(2) Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.
(3) Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(4) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.
(5) Represents sales excluding Russia for the three months ended October 2, 2026 and October 3, 2025. 9
(2) Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.
(3) Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(4) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.
(2) Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.
(3) Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(4) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.
(5) Represents sales excluding Russia for the nine months ended October 2, 2026 and October 3, 2025. 10
(1) Represents payments related to due diligence, transaction and other related costs. 11
(1) Exclude net sales relating to Russia of $37.7 million and $40.4 million for the three months ended October 2, 2026 and October 3, 2025, respectively, and $110.2 million and $108.8 million for the nine months ended October 2, 2026 and October 3, 2025, respectively.
(2) Adjusted gross profit is a non-GAAP measure that excludes inventory fair value step-up from gross profit. We introduced this measure in 2026 and have presented the prior-periods on the same basis.
(3) Numbers calculated following the same definition as Adjusted gross profit for total Company.
6.50% Series A Mandatory Convertible Preferred Stock, 175,000 shares issued and outstanding at October 2, 171,097 — 2026; no shares issued or outstanding at December 31, 2025 Common stock - $0.001 par value - 600,000,000 shares authorized, 62,175,585 and 60,721,079 shares 62 61 outstanding as of October 2, 2026 and December 31, 2025, respectively Additional paid-in capital 2,057,487 1,904,889 Retained earnings 894,387 800,806 Accumulated other -562,976 -539,716 comprehensive loss Total ESAB Corporation equity 2,560,057 2,166,040 Noncontrolling interest 45,556 45,489 Total equity 2,605,613 2,211,529 Total liabilities and equity $ 6,495,211 $ 4,766,094
Nine Months Ended October 2, 2026 October 3, 2025 ────────────────────────────────────────────────────────────────────────────── Cash flows from operating activities: Net income $ 123,500 $ 194,457 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation, amortization and other 92,971 58,731 impairment charges Net gain on sale of property, -81 -5,697 plant and equipment Stock-based compensation 18,467 12,542 expense Deferred income -21,989 -7,707 tax benefit Amortization of debt issuance 8,930 1,882 costs Changes in operating assets and liabilities: Trade -45,481 -50,381 receivables, net Inventories, net -47,321 -28,924 Accounts payable 33,075 -9,893 Other operating assets and -9,054 -1,496 liabilities Net cash provided by 153,017 163,514 operating activities Cash flows from investing activities: Purchases of property, plant -49,700 -27,654 and equipment Proceeds from sale of 735 4,731 property, plant and equipment Acquisitions, net of cash -1,469,372 -439,669 received Other investing — 539 Net cash used in investing -1,518,337 -462,053 activities Cash flows from financing activities: Proceeds from issuance of 171,097 — Preferred stock, net Proceeds from issuance of 139,796 — Common stock, net Proceeds from borrowings on 1,000,000 — Senior Notes Repayments of borrowings on — -10,000 Term Loans Proceeds from borrowings on revolving 1,021,894 359,591 credit facilities and other Repayments of borrowings on revolving -917,937 -90,442 credit facilities and other Payment of debt -17,717 — issuance costs Payment of -19,690 -15,821 dividends Payment of preferred -1,390 — dividends Distributions to noncontrolling -2,160 -3,057 interest holders Other financing -5,687 -13,008 Net cash provided by 1,368,206 227,263 financing activities Effect of foreign exchange rates on Cash -101 40,137 and cash equivalents Increase (decrease) in 2,785 -31,139 Cash and cash equivalents Cash and cash equivalents, 185,863 249,358 beginning of period Cash and cash equivalents, end $ 188,648 $ 218,219 of period
Full text with the tables
ESAB Corporation Announces Third Quarter 2026 Results
• Record total sales; increased 13.3%, with core organic sales up 2.3%
• Core organic growth in both segments
• EBXai driving margin expansion
• Updating 2026 outlook
North Bethesda, MD, November 4, 2026 -- ESAB Corporation (“ESAB” or the
“Company”) (NYSE: ESAB), a focused premier industrial compounder, today
announced financial results for the third quarter of 2026.
ESAB reported record third quarter sales of $825 million, an increase of 13.3%
on a reported basis or an increase of 2.3% on a core organic growth basis before
acquisitions and currency translation, as compared to the prior year quarter.
ESAB also reported third quarter net income from continuing operations
attributable to ESAB of $41 million or $0.61 diluted earnings per share and core
adjusted net income of $83 million or $1.30 diluted earnings per share. Core
adjusted EBITDA of $156 million rose 17.0% and core adjusted EBITDA margin
expanded by 40 basis points on a year-over-year basis to 19.8%.
“ESAB delivered record third quarter core sales and adjusted EBITDA, with
organic growth in both segments, despite a dynamic global environment and
continued inflationary pressure. We improved sales, margins and cash generation
sequentially. Disciplined execution, investment in growth and our EBXai
operating system are delivering results,” said Shyam P. Kambeyanda, ESAB
President and CEO. “We built this enterprise to win in any market, and we are
executing with urgency to capture the opportunities ahead.”
“ESAB is setting the standard for complete workflow solutions,” Kambeyanda
added. “With our new products, and the acquisitions of EWM and Eddyfi, we now
serve our customers across the entire life of their most critical assets, from
the first cut and weld through decades of inspection, monitoring and repair. At
Fabtech, customers saw the full strength and power of our enterprise firsthand,
and their response was overwhelmingly positive. We are beginning to convert this
into new growth, from cross-selling opportunities at ESAB and Eddyfi. Lastly, we
remain relentlessly focused on execution and on turning our unrivaled position
into lasting value for our shareholders.”
Updating Full Year 2026 Outlook
ESAB has updated its full-year 2026 outlook, which now projects total core sales
growth of 13.1% to 13.3%, compared with the previous guidance of 11.0% to 14.0%.
Within this growth, core organic sales growth is now expected to be 1.6% to
2.0%, down from the prior range of 2.0% to 4.0%. The contribution from M&A has
increased to appro ximately 9.5% from the prior guidance of 9.0%, and the
anticipated FX impact has increased to approximately 2.0% from the prior range
of 0.0% to 1.0%. As a result, the company has adjusted its core adjusted EBITDA
forecast to a range of $603 million to $607 million, down from the previous $615
million to $625 million. The outlook for core adjusted EPS has been adjusted to
a range of $5.28 to $5.33, from the prior $5.40 to $5.50.
About ESAB Corporation
Founded in 1904, ESAB Corporation is a focused industrial compounder. The
Company’s rich history of innovative products, workflow solutions and its
business system ESAB Business Excellence with AI (“EBXai”), enables the
Company’s purpose of Shaping the world we imagine TM . ESAB Corporation is based
in North Bethesda, Maryland and employs approximately 11,300 associates and
serves customers in approximately 150 countries. To learn more, visit
www.ESABcorporation.com.
Conference Call and Webcast
The Company will hold a conference call to discuss its third quarter 2026
results beginning at 8:00 a.m. Eastern on Wednesday, November 4, 2026, which
will be open to the public by calling +1-585-542-9983 (U.S. callers) and
+1-833-461-5787 (International callers) and referencing the conference ID number
463934714 and through webcast via ESAB’s website www.ESABcorporation.com under
the “Investors” section. Access to a supplemental slide presentation can also be
found on ESAB's website under the same heading. Both the audio of this call and
the slide presentation will be archived on the website later today and will be
available until the next quarterly call. The Company’s quarterly report on Form
10-Q for the fiscal quarter ended October 2, 2026, filed November 4, 2026, is
also available on ESAB’s website under the “Investors” section.
1
Non-GAAP Financial Measures and Other Adjustments
ESAB has provided in this press release financial information that has not been
prepared in accordance with accounting principles generally accepted in the
United States (“non-GAAP”). ESAB presents some of these non-GAAP financial
measures including and excluding Russia d ue to economic and political
volatility caused by the war in Ukraine, which results in enhanced investor
interest in this information. Core non-GAAP financial measures exclude Russia
for the three and nine months ended October 2, 2026 and October 3, 2025 . T hese
non-GAAP financial measures may include one or more of the following: adjusted
net income from continuing operations, Core adjusted net income from continuing
operations, adjusted gross profit, adjusted EBITDA (earnings before interest,
taxes, Restructuring and other related charges, Pension settlement loss,
acquisition transaction, due diligence and integration expenses, amortization of
intangibles and fair value step up on acquired inventories, depreciation and
other amortization and other costs such as compensation expense related to the
Performance Option Awards), Core adjusted EBITDA, organic sales, Core organic
sales, adjusted free cash flow and ratios based on the foregoing measures. ESAB
also provides adjusted EBITDA and adjusted EBITDA margin on a segment basis, as
well as Core adjusted EBITDA and Core adjusted EBITDA margin on a segment basis.
Adjusted gross profit represents Gross profit excluding inventory fair value
step-up, which is the fair value adjustment to acquired inventory recognized in
cost of sales as that inventory is sold. Adjusted gross profit margin is
adjusted gross profit as a percentage of net sales. ESAB presents adjusted gross
profit to show gross profit excluding the purchase accounting effect of acquired
inventory, which management uses to supplement GAAP results and evaluate
underlying gross margin trends across periods affected by acquisitions. ESAB is
presenting adjusted gross profit for the first time, and prior-period amounts
are calculated on the same basis. ESAB will present adjusted gross profit on
this basis for all periods presented going forward. If ESAB changes this
definition, it will revise prior periods presented for consistency and disclose
the change and its effect on margin.
Adjusted net income from continuing operations represents Net income from
continuing operations attributable to ESAB Corporation, excluding Restructuring
and other related charges, Pension settlement loss, acquisition transaction, due
diligence and integration expenses, amortization of intangibles and fair value
step up on acquired inventories and other costs such as compensation expense
related to the Performance Option Awards. Adjusted net income, includes the tax
effect of non-GAAP adjusting items at applicable tax rates and excludes the
impact of discrete tax charges or gains in each period. ESAB also presents
adjusted net income margin from continuing operations, which is subject to the
same adjustments as adjusted net income from continuing operations. Adjusted net
income per diluted share from continuing operations is a calculation of adjusted
net income from continuing operations over the weighted-average diluted shares
outstanding. ESAB also presents Core adjusted net income from continuing
operations and Core adjusted net income per share - diluted from continuing
operations, which are subject to the same adjustments as Adjusted net income
from continuing operations and Adjusted net income per diluted share from
continuing operations, further removing the impact of Russia for the three and
nine months ended October 2, 2026 and October 3, 2025. We present the earnings
per share-related non-GAAP measures on a basis that assumes the MCPS had already
been converted as of the beginning of the applicable period (and accordingly
also exclude the dividends accrued on the MCPS during such period, since such
dividends would no longer be paid once the MCPS convert). We believe this
presentation provides useful information to investors by helping them understand
what the net impact will be on ESAB’s earnings per share - related measures once
the MCPS convert into ESAB’s Common stock.
Adjusted EBITDA excludes from Net income from continuing operations the effect
of Income tax expense, Interest expense and other, net, Restructuring and other
related charges, Pension settlement loss, acquisition transaction, due diligence
and integration expenses, amortization of intangibles and fair value step up on
acquired inventories, depreciation and other amortization and other costs such
as compensation expense related to the Performance Option Awards. ESAB presents
adjusted EBITDA margin, which is subject to the same adjustments as adjusted
EBITDA. Further, ESAB presents these non-GAAP performance measures on a segment
basis, which excludes the impact of Restructuring and other related charges,
acquisition transaction, due diligence and integration expenses, amortization of
intangibles and fair value step up on acquired inventories, depreciation and
other amortization and other costs such as compensation expense related to the
Performance Option Awards from operating income. ESAB also presents Core
adjusted EBITDA and Core adjusted EBITDA margin, which are subject to the same
adjustments as Ad justed EBITDA and Adjusted EBITDA margin, respectively,
further removing the impact of Russia for the three and nine months ended
October 2, 2026 and October 3, 2025 .
ESAB presents organic sales, which excludes the impact of acquisitions and
foreign exchange rate fluctuations and presents core organic sales, which
further excludes the impact of the Russia business for the three and nine months
ended October 2, 2026 and October 3, 2025 .
2
Adjusted free cash flow represents cash flows from operating activities
excluding cash outflows related to discontinued operations and acquisition-
related payments less purchases of property, plant and equipment.
These non-GAAP financial measures assist ESAB management in comparing its
operating performance over time because certain items may obscure underlying
business trends and make comparisons of long-term performance difficult, as they
are of a nature and/or size that occur with inconsistent frequency or relate to
unusual events or discrete restructuring plans and other initiatives that are
fundamentally different from the ongoing productivity and core business of the
Company.
ESAB management also believes that presenting these measures allows investors to
view its performance using the same measures that the Company uses in evaluating
its financial and business performance and trends.
Non-GAAP financial measures should not be considered in isolation from, or as a
substitute for, financial information calculated in accordance with GAAP.
Investors are encouraged to review the reconciliation of these non-GAAP measures
to their most directly comparable GAAP financial measures. A reconciliation of
non-GAAP financial measures presented above to GAAP results has been provided in
the financial tables included in this press release.
Forward-Looking Statements
This press release includes forward-looking statements, including forward-
looking statements within the meaning of the U.S. Private Securities Litigation
Reform Act of 1995. Such forward-looking statements include, but are not limited
to, statements concerning the Company’s plans, goals, objectives, outlook,
expectations, and intentions, and other statements that are not historical or
current fact. Forward-looking statements are based on the Company’s current
expectations and involve risks and uncertainties that could cause actual results
to differ materially from those expressed or implied in such forward-looking
statements, including general risks and uncertainties such as market conditions,
economic conditions, geopolitical events, changes in laws, regulations or
accounting rules, fluctuations in interest rates, terrorism, wars or conflicts,
major health concerns, natural disasters or other disruptions of expected
business conditions. Factors that could cause the Company’s results to differ
materially from current expectations include, but are not limited to, risks
related to the impact of the war in Ukraine and the conflict in the Middle East
and the resulting escalating geopolitical tensions; impact of supply chain
disruptions; the impact of creditworthiness and financial viability of
customers; impact of inflationary pressures, tariffs and trade policies, foreign
exchange fluctuations and commodity prices; other impacts on the Company’s
business and ability to execute business continuity plans; and the other factors
detailed in the Company’s Annual Report on Form 10-K for the year ended December
31, 2025 filed with the U.S. Securities and Exchange Commission (“SEC”) on
February 20, 2026, and the Form 10-Q for the quarterly period ended April 3,
2026 filed with the SEC on May 7, 2026 and the Form 10-Q for the quarterly
period ended July 3, 2026 filed with the SEC on August 6, 2026, as well as other
risks discussed in the Company’s filings with the SEC. In addition, these
statements are based on assumptions that are subject to change. This press
release speaks only as of the date hereof. The Company disclaims any duty to
update the information herein.
Investor Relations Contact:
Mark Barbalato
Vice President, Investor Relations
E-mail: [email protected]
Phone: 1-301-323-9098
Media Contact:
Tilea Coleman
Vice President, Corporate Communications
E-mail: [email protected]
Phone: 1-301-323-9092
3
ESAB CORPORATION
CONSOLIDATED AND CONDENSED STATEMENTS OF OPERATIONS
Dollars in thousands, except per share data
(Unaudited)
Three Nine
Months October October Months October October
Ended 2, 2026 3, 2025 Ended 2, 2026 3, 2025
──────────────────────────────────────────────────────────────────────────────
Net $ 824,521 $ 727,845 $ 2,377,… $ 2,121,5…
sales
Cost
of 500,878 458,545 1,471,… 1,331,0…
sales
Gross 323,643 269,300 905,966 790,549
profit
Selli…
gener…
and 220,382 158,335 605,023 454,756
admin…
expen…
Restr…
and
other 11,329 4,347 39,807 10,236
relat…
charg…
Opera… 91,932 106,618 261,136 325,557
income
Inter…
expen…
and 36,511 23,584 92,711 61,365
other,
net
Income
from
conti…
opera… 55,421 83,034 168,425 264,192
before
income
taxes
Income
tax 13,261 17,694 38,073 56,476
expen…
Net
income
from 42,160 65,340 130,352 207,716
conti…
opera…
Loss
from
disco…
opera… -1,885 -8,819 -6,852 -13,259
net
of
taxes
Net 40,275 56,521 123,500 194,457
income
Income
attri…
to
nonco… -1,353 -1,674 -4,580 -5,364
inter…
net of
taxes
Net
income
attri… 38,922 54,847 118,920 189,093
to
ESAB
Corpo…
Manda…
conve…
prefe… -2,843 — -4,233 —
stock
divid…
Net
income
attri… $ 36,079 $ 54,847 $ 114,687 $ 189,093
to
common
stock…
Earni…
(loss)
per
share
–
basic
Income
from $ 0.61 $ 1.05 $ 1.97 $ 3.33
conti…
opera…
Loss
on -0.03 -0.15 -0.11 -0.22
disco…
opera…
Net
income
per $ 0.58 $ 0.90 $ 1.86 $ 3.11
share
–
basic
Earni…
(loss)
per
share
–
dilut…
Income
from $ 0.61 $ 1.04 $ 1.96 $ 3.29
conti…
opera…
Loss
on -0.03 -0.14 -0.11 -0.22
disco…
opera…
Net
income
per $ 0.58 $ 0.90 $ 1.85 $ 3.07
share
–
dilut…
4
ESAB CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Dollars in millions, except per share data
(Unaudited)
Three Octob… Octo… Nine Octo… Octob…
Mont… 2, 3, Months 2, 3,
Ende… 2026 2025 Ended… 2026 2025
──────────────────────────────────────────────────────────────────────────────
Adju…
Net
Inco…
Net
inco…
from $ 42.2 $ 65.3 $ 130.4 $ 207.7
cont…
oper…
(GAA…
Inco…
attr…
to
nonc… -1.4 -1.7 -4.6 -5.4
inte…
net
of
taxes
MCPS -2.8 — -4.2 —
divi…
Net
inco…
from
cont…
oper… 38.0 63.7 121.5 202.4
attr…
to
comm…
shar…
Rest…
and
other
rela… 11.3 4.3 39.8 10.2
char…
–
pret…
Acqu…
and
other
rela… 39.9 16.5 108.8 47.7
char…
–
pret…
Othe… 3.2 — 3.8 —
Tax
effe…
on -12.3 -3.6 -36.0 -12.4
above
item…
Disc…
tax 1.5 2.3 5.3 2.3
adju…
MCPS
divi…
assu… 2.8 — 4.2 —
"if-…
meth…
Adju…
net
inco…
from 84.5 83.2 247.6 250.2
cont…
oper…
(non…
Adju…
net
inco…
from
cont… -1.5 -2.7 -1.3 -8.7
oper…
attr…
to
Russ…
(non…
Core
adju…
net
inco… $ 83.0 $ 80.5 $ 246.2 $ 241.5
from
cont…
oper…
(non…
Adju…
net
inco…
marg… 10.2 % 11.4 % 10.4 % 11.8 %
from
cont…
oper…
Adju…
Net
Inco…
Per
Share
Net
inco…
per
share
– $ 0.61 $ 1.04 $ 1.96 $ 3.29
dilu…
from
cont…
oper…
(GAA…
Rest…
and
other
rela… 0.18 0.07 0.64 0.17
char…
–
pret…
Acqu…
and
other
rela… 0.63 0.27 1.75 0.78
char…
–
pret…
Othe… 0.05 — 0.06 —
Tax
effe…
on -0.19 -0.06 -0.58 -0.20
above
item…
Disc…
tax 0.02 0.04 0.08 0.04
adju…
MCPS
divi…
assu… 0.03 — 0.05 —
"if-…
meth…
Adju…
net
inco…
per
share
– 1.32 1.36 3.96 4.08
dilu…
from
cont…
oper…
(non…
Adju…
net
inco…
per
share
–
dilu… -0.02 -0.04 -0.02 -0.14
from
cont…
oper…
attr…
to
Russ…
(non…
Core
adju…
net
inco…
per
share $ 1.30 $ 1.32 $ 3.94 $ 3.94
–
dilu…
from
cont…
oper…
(non…
__________
(1) Numbers may not sum due to rounding.
(2) Includes severance and other termination benefits, including outplacement
services as well as the cost of relocating associates, relocating equipment,
lease termination expenses, impairment of long-lived assets, costs associated
with disposing of discontinued products and other costs in connection with the
closure and optimization of facilities and product lines.
(3) Includes transaction, diligence and integration expenses totaling $8.8
million and $43.9 million for the three and nine months ended October 2, 2026,
respectively, and $6.1 million and $20.4 million for the three and nine months
ended October 3, 2025, respectively. Additionally, it includes amortization of
intangibles and fair value step up on acquired inventories totaling $31.2
million and $60.1 million for the three and nine months ended October 2, 2026,
respectively, and $10.3 million and $27.3 million for the three and nine months
ended October 3, 2025, respectively. Additionally, includes $4.8 million of
bridge loan commitment fees related to the Eddyfi Technologies acquisition for
the nine months ended October 2, 2026.
(4) Includes the impact of the Performance Option Awards granted in June and
July 2026. These awards were non-cash, one-time, non-recurring grants with a
different structure and size than the Company’s annual equity compensation
program totaling $2.8 million and $3.5 million for the three and nine months
ended October 2, 2026, respectively.
(5) This line item reflects the aggregate tax effect of all non-tax adjustments
reflected in the preceding line items of the table. ESAB estimates the tax
effect of each adjustment by applying ESAB’s overall estimated effective tax
rate to the pretax amount, unless the nature of the
5
item and/or tax jurisdiction in which the item has been recorded requires
application of a specific tax rate or tax treatment, in which case the tax
effect of such item is estimated by applying such specific tax rate or tax
treatment. The MCPS dividends are not tax deductible and therefore the tax
effect of the adjustments reflected in the table above does not include any tax
impact of the MCPS dividends.
(6) For 2026, discrete adjustments relate to tax effects from the Eddyfi
transaction.
(7) In June 2026, the Company issued $175.0 million in aggregate liquidation
preference of the MCPS. Dividends on the MCPS are payable on a cumulative basis
at an annual rate of 6.50% on the liquidation preference of $1,000 per share.
Unless earlier converted, each share of MCPS will automatically convert on
approximately June 2029 into between 7.1806 and 8.2576 shares of ESAB's Common
stock, subject to further anti-dilution adjustments. The number of shares of
ESAB's Common stock issuable on conversion of the MCPS will be determined based
on the volume weighted average price ("VWAP") per share of the Company's Common
stock over the 20 consecutive trading day period commencing on, and including,
the 21st scheduled trading day immediately preceding the final dividend payment
date. For the purposes of calculating adjusted net income per share, the Company
has excluded the paid and anticipated MCPS cash dividends and assumed the 'if-
converted' method of share dilution (the incremental shares of Common stock
deemed outstanding applying the 'if-converted' method of calculating share
dilution are referred to as the 'Converted Shares'). Under this method,
approximately 1.4 million and 0.7 million Converted Shares were included in
weighted average diluted shares outstanding for the three and nine months ended
October 2, 2026, respectively. We believe this presentation provides useful
information to investors by helping them understand what the net impact will be
on ESAB’s earnings per share - related measures once the MCPS convert into
ESAB’s Common stock.
(8) Numbers calculated following the same definition as Adjusted net income from
continuing operations for total Company.
6
ESAB CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Dollars in millions
(Unaudited)
T… N…
M… M…
E… E…
O… O…
2, E… 2, E…
2… & 2… &
A… A… T… A… A… T…
──────────────────────────────────────────────────────────────────────────────
…
…
… $ 4… $ …
…
…
…
…
… 1… …
…
…
…
… 3… …
…
…
…
… $ 2… $ 6… $ 9… $ … $ … $ …
…
…
…
…
…
…
… 1… 0… 1… … … …
…
…
…
…
… 2… 1… 3… … … …
…
…
…
… 5… 7… 1… … … …
…
…
… 1… 1… 3… … … …
…
… 6… 9… 1… … … …
…
…
…
… — 3… 3… — … …
…
…
…
…
… $ 6… $ 8… $ 1… $ … $ … $ …
…
…
…
… 1… % 1… % 1… % … % … % … %
…
…
…
…
… 1… % 1… % 1… % … % … % … %
…
…
__________
(1) Numbers may not sum due to rounding.
(2) Includes severance and other termination benefits, including outplacement
services as well as the cost of relocating associates, relocating equipment,
lease termination expenses, impairment of long-lived assets, costs associated
with disposing of discontinued products and other costs in connection with the
closure and optimization of facilities and product lines.
(3) Includes transaction, diligence and integration expenses totaling $8.8
million and $43.9 million for the three and nine months ended October 2, 2026,
respectively, and amortization of intangibles and fair value step up on acquired
inventories totaling $31.2 million and $60.1 million for the three and nine
months ended October 2, 2026, respectively.
(4) Includes the impact of the Performance Option Awards granted in June and
July 2026. These awards were non-cash, one-time, non-recurring grants with a
different structure and size than the Company’s annual equity compensation
program totaling $2.8 million and $3.5 million for the three and nine months
ended October 2, 2026, respectively.
(5) Numbers calculated following the same definition as Adjusted EBITDA for
total Company.
(6) Net sales w ere $37.7 million and $110.2 million r elating to Russia for the
three and nine months ended October 2, 2026, respectively.
7
ESAB CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Dollars in millions
(Unaudited)
T… N…
M… M…
E… E…
O… O…
3, E… 3, E…
2… & 2… &
A… A… T… A… A… T…
──────────────────────────────────────────────────────────────────────────────
…
…
… $ 6… $ …
…
…
…
…
… 1… …
…
…
…
… 2… …
…
…
…
… $ 4… $ 6… $ 1… $ … $ … $ …
…
…
…
…
…
…
… 2… 2… 4… … … …
…
…
…
…
… 5… 1… 1… … … …
…
…
…
… 3… 8… 1… … … …
…
…
…
… 5… 8… 1… … … …
…
…
…
… — 6… 6… — … …
…
…
…
…
… $ 5… $ 7… $ 1… $ … $ … $ …
…
…
…
… 1… % 1… % 1… % … % … % … %
…
…
…
…
… 1… % 1… % 1… % … % … % … %
…
…
(1) Numbers may not sum due to rounding.
(2) Includes severance and other termination benefits, including outplacement
services as well as the cost of relocating associates, relocating equipment,
lease termination expenses, impairment of long-lived assets and other costs in
connection with the closure and optimization of facilities and product lines.
(3) Includes transaction, diligence and integration expenses totaling $6.1
million and $20.4 million for the three and nine months ended October 3, 2025,
respectively, and amortization of intangibles and fair value step up on acquired
inventories totaling $10.3 million and $27.3 million for the three and nine
months ended October 3, 2025, respectively.
(4) Numbers calculated following the same definition as Adjusted EBITDA for
total Company.
(5) Net sales were $40.4 million and $108.8 million relating to Russia for the
three and nine months ended October 3, 2025, respectively.
8
ESAB CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Change in Net Sales
Dollars in millions
(Unaudited)
N… E…
S… &
A… A… T…
──────────────────────────────────────────────────────────────────────────────
$ C… $ C… $ C…
% % %
…
…
…
… $ 29… $ 43… $ 72…
…
…
…
…
…
…
…
…
… 2.3 0.8 % 11… 2.7 % 13… 1.9 %
…
…
… 34… 11… % 43… 9.9 % 77… 10… %
…
… 8.1 2.8 % -2… -0… % 5.5 0.8 %
…
…
… 44… 15… % 52… 12… % 96… 13… %
…
…
…
…
…
… $ 33… $ 48… $ 82…
…
…
…
…
(1) Numbers may not sum due to rounding.
(2) Excludes the impact of acquisitions and foreign exchange rate fluctuations,
thus providing a measure of change due to organic growth factors such as price,
product mix and volume.
(3) Represents the incremental sales in comparison to the portion of the prior
period during which we did not own the business.
(4) Represents the difference between prior year sales valued at the actual
prior year foreign exchange rates and prior year sales valued at current year
foreign exchange rates.
C… E…
S… &
A… A… T…
──────────────────────────────────────────────────────────────────────────────
$ C… $ C… $ C…
% % %
…
…
…
… $ 29… $ 39… $ 68…
…
…
…
…
…
…
…
…
…
… 2.3 0.8 % 13… 3.4 % 15… 2.3 %
…
…
… 34… 11… % 43… 10… % 77… 11… %
…
… 8.1 2.8 % -2… -0… % 6.2 0.9 %
…
…
… 44… 15… % 54… 13… % 99… 14… %
…
…
…
…
…
… $ 33… $ 44… $ 78…
…
…
…
…
(1) Numbers may not sum due to rounding.
(2) Excludes the impact of acquisitions and foreign exchange rate fluctuations,
thus providing a measure of change due to organic growth factors such as price,
product mix and volume.
(3) Represents the incremental sales in comparison to the portion of the prior
period during which we did not own the business.
(4) Represents the difference between prior year sales valued at the actual
prior year foreign exchange rates and prior year sales valued at current year
foreign exchange rates.
(5) Represents sales excluding Russia for the three months ended October 2, 2026
and October 3, 2025.
9
ESAB CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Change in Net Sales
Dollars in millions
(Unaudited)
N… E…
S… &
A… A… T…
──────────────────────────────────────────────────────────────────────────────
$ C… $ C… $ C…
% % %
…
…
…
… $ 85… $ 1,… $ 2,…
…
…
…
…
…
…
…
…
… 14… 1.6 % 5.0 0.4 % 19… 0.9 %
…
…
… 43… 5.1 % 13… 10… % 17… 8.3 %
…
… 27… 3.2 % 33… 2.7 % 61… 2.9 %
…
…
… 85… 10… % 17… 13… % 25… 12… %
…
…
…
…
…
… $ 94… $ 1,… $ 2,…
…
…
…
…
(1) Numbers may not sum due to rounding.
(2) Excludes the impact of acquisitions and foreign exchange rate fluctuations,
thus providing a measure of change due to organic growth factors such as price,
product mix and volume.
(3) Represents the incremental sales in comparison to the portion of the prior
period during which we did not own the business.
(4) Represents the difference between prior year sales valued at the actual
prior year foreign exchange rates and prior year sales valued at current year
foreign exchange rates.
C… E…
S… &
A… A… T…
──────────────────────────────────────────────────────────────────────────────
$ C… $ C… $ C…
% % %
…
…
…
… $ 85… $ 1,… $ 2,…
…
…
…
…
…
…
…
…
…
… 14… 1.6 % 11… 1.0 % 25… 1.3 %
…
…
… 43… 5.1 % 13… 11… % 17… 8.7 %
…
… 27… 3.2 % 26… 2.3 % 53… 2.7 %
…
…
… 85… 10… % 16… 14… % 25… 12… %
…
…
…
…
…
… $ 94… $ 1,… $ 2,…
…
…
…
…
(1) Numbers may not sum due to rounding.
(2) Excludes the impact of acquisitions and foreign exchange rate fluctuations,
thus providing a measure of change due to organic growth factors such as price,
product mix and volume.
(3) Represents the incremental sales in comparison to the portion of the prior
period during which we did not own the business.
(4) Represents the difference between prior year sales valued at the actual
prior year foreign exchange rates and prior year sales valued at current year
foreign exchange rates.
(5) Represents sales excluding Russia for the nine months ended October 2, 2026
and October 3, 2025.
10
ESAB CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Adjusted Free Cash Flow
Dollars in millions
(Unaudited)
Three Nine
Months October October Months October October
Ended 2, 2026 3, 2025 Ended 2, 2026 3, 2025
──────────────────────────────────────────────────────────────────────────────
Net
cash
provi…
by $ 72.7 $ 81.5 $ 153.0 $ 163.5
opera…
activ…
(GAAP)
Purch…
of
prope…
plant -18.3 -11.3 -49.7 -27.7
and
equip…
(GAAP)
Payme…
relat…
to 3.7 3.6 15.5 10.8
disco…
opera…
Acqui… 1.9 12.6 22.1 16.6
payme…
Adjus…
free
cash $ 60.0 $ 86.4 $ 140.9 $ 163.2
flow
(non-…
(1) Represents payments related to due diligence, transaction and other related
costs.
11
ESAB CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Adjusted Gross Profit
Dollars in millions
(Unaudited)
Thr… Oct… Oct… Nine Oct… Oct…
Mon… 2, 3, Mon… 2, 3,
End… 2026 2025 End… 2026 2025
──────────────────────────────────────────────────────────────────────────────
Net $ 824… $ 727… $ 2,3… $ 2,1…
sa…
Co…
net 786… 687… 2,2… 2,0…
sa…
Gr… 323… 269… 906… 790…
pr…
Gr…
pr… 39.3 % 37.0 % 38.1 % 37.3 %
ma…
(G…
Gr…
pr… 323… 269… 906… 790…
(G…
In…
fa… 2.6 0.5 5.3 2.0
va…
st…
Ad…
gr… $ 326… $ 269… $ 911… $ 792…
pr…
(n…
Ad…
gr…
pr… 39.6 % 37.1 % 38.3 % 37.4 %
ma…
(n…
Ad…
gr…
pr…
re… 10.0 11.0 25.4 27.4
to
Ru…
(n…
Ad…
co…
gr… $ 316… $25… $885… $765…
pr…
(n…
Ad…
co…
gr… 40.2 % 37.7 % 39.1 % 38.0 %
pr…
ma…
(n…
(1) Exclude net sales relating to Russia of $37.7 million and $40.4 million for
the three months ended October 2, 2026 and October 3, 2025,
respectively, and $110.2 million and $108.8 million for the nine months ended
October 2, 2026 and October 3, 2025, respectively.
(2) Adjusted gross profit is a non-GAAP measure that excludes inventory fair
value step-up from gross profit. We introduced this measure in 2026 and have
presented the prior-periods on the same basis.
(3) Numbers calculated following the same definition as Adjusted gross profit
for total Company.
(4) Numbers may not sum due to rounding.
12
ESAB CORPORATION
2026
Outlook
Dollars in millions, except per share amounts
(Unaudited)
ESAB
2026 Previous New
Outlook Guidance Guidance
──────────────────────────────────────────────────────────────────────────────
2025
Core net $ 2,700.4 $ 2,700.4
sales
Organic 2.0% - 1.6% -
growth 4.0% 2.0%
Acquisi… ~9.0% ~9.5%
Currency 0.0% - ~2.0%
1.0%
2026
Core net 11.0% - 13.1% -
sales 14.0% 13.3%
growth
range
2025
Core $ 540.0 $ 540.0
adjusted
EBITDA
2026
Core $615 - $603 -
adjusted $625 $607
EBITDA
range
2025
Core $ 5.27 $ 5.27
adjusted
EPS
2026
Core $5.40 - $5.28 -
adjusted $5.50 $5.33
EPS
range
13
ESAB CORPORATION
CONSOLIDATED AND CONDENSED BALANCE SHEETS
Dollars in thousands, except share and per share amounts
(Unaudited)
October 2, 2026 December 31, 2025
──────────────────────────────────────────────────────────────────────────────
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $ 188,648 $ 185,863
Trade receivables, less
allowance for 551,661 451,298
credit losses of $21,992 and
$21,765
Inventories, net 570,162 481,765
Prepaid expenses 80,106 66,103
Other current assets 103,695 76,876
Total current assets 1,494,272 1,261,905
Property, plant and equipment, 387,536 381,876
net
Goodwill 2,738,125 1,949,702
Intangible assets, net 1,352,690 673,006
Lease assets - right of use 139,281 113,310
Other assets 383,307 386,295
Total assets $ 6,495,211 $ 4,766,094
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Current portion of debt $ 9,357 $ 2,412
Accounts payable 398,984 360,391
Accrued liabilities 368,219 301,986
Total current liabilities 776,560 664,789
Long-term debt 2,319,712 1,232,540
Other liabilities 793,326 657,236
Total liabilities 3,889,598 2,554,565
Equity:
Preferred stock - $0.001 par
value -
20,000,000 shares authorized:
6.50% Series A Mandatory
Convertible
Preferred Stock, 175,000
shares issued
and outstanding at October 2, 171,097 —
2026; no
shares issued or outstanding
at December
31, 2025
Common stock - $0.001 par
value -
600,000,000 shares authorized,
62,175,585 and 60,721,079
shares 62 61
outstanding as of October 2,
2026 and
December 31, 2025,
respectively
Additional paid-in capital 2,057,487 1,904,889
Retained earnings 894,387 800,806
Accumulated other -562,976 -539,716
comprehensive loss
Total ESAB Corporation equity 2,560,057 2,166,040
Noncontrolling interest 45,556 45,489
Total equity 2,605,613 2,211,529
Total liabilities and equity $ 6,495,211 $ 4,766,094
14
ESAB CORPORATION
CONSOLIDATED AND CONDENSED STATEMENTS OF CASH FLOWS
Dollars in thousands
(Unaudited)
Nine Months Ended October 2, 2026 October 3, 2025
──────────────────────────────────────────────────────────────────────────────
Cash flows from
operating
activities:
Net income $ 123,500 $ 194,457
Adjustments to
reconcile net
income to
net cash
provided by
operating
activities:
Depreciation,
amortization and
other 92,971 58,731
impairment
charges
Net gain on sale
of property, -81 -5,697
plant and
equipment
Stock-based
compensation 18,467 12,542
expense
Deferred income -21,989 -7,707
tax benefit
Amortization of
debt issuance 8,930 1,882
costs
Changes in
operating assets
and
liabilities:
Trade -45,481 -50,381
receivables, net
Inventories, net -47,321 -28,924
Accounts payable 33,075 -9,893
Other operating
assets and -9,054 -1,496
liabilities
Net cash
provided by 153,017 163,514
operating
activities
Cash flows from
investing
activities:
Purchases of
property, plant -49,700 -27,654
and
equipment
Proceeds from
sale of 735 4,731
property, plant
and equipment
Acquisitions,
net of cash -1,469,372 -439,669
received
Other investing — 539
Net cash used in
investing -1,518,337 -462,053
activities
Cash flows from
financing
activities:
Proceeds from
issuance of 171,097 —
Preferred
stock, net
Proceeds from
issuance of 139,796 —
Common stock,
net
Proceeds from
borrowings on 1,000,000 —
Senior Notes
Repayments of
borrowings on — -10,000
Term Loans
Proceeds from
borrowings on
revolving 1,021,894 359,591
credit
facilities and
other
Repayments of
borrowings on
revolving -917,937 -90,442
credit
facilities and
other
Payment of debt -17,717 —
issuance costs
Payment of -19,690 -15,821
dividends
Payment of
preferred -1,390 —
dividends
Distributions to
noncontrolling -2,160 -3,057
interest
holders
Other financing -5,687 -13,008
Net cash
provided by 1,368,206 227,263
financing
activities
Effect of
foreign exchange
rates on Cash -101 40,137
and cash
equivalents
Increase
(decrease) in 2,785 -31,139
Cash and cash
equivalents
Cash and cash
equivalents, 185,863 249,358
beginning of
period
Cash and cash
equivalents, end $ 188,648 $ 218,219
of period
15